Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$275K Buy
13,081
+1,983
+18% +$35.2K 0.01% 1095
2026
Q2
$180K Sell
11,098
-1,926
-15% -$34.3K 0.01% 1343
2026
Q1
$248K Buy
13,024
+2,274
+21% +$43.9K 0.01% 964
2025
Q4
$176K Buy
10,750
+578
+6% +$10.2K 0.01% 1135
2025
Q3
$191K Sell
10,172
-3,384
-25% -$60.7K 0.01% 1009
2025
Q2
$274K Buy
13,556
+6,662
+97% +$115K 0.02% 719
2025
Q1
$94.8K Buy
6,894
+5,325
+339% +$73.3K 0.01% 1305
2024
Q4
$18.6K Buy
1,569
+146
+10% +$2.3K ﹤0.01% 2299
2024
Q3
$25.5K Buy
1,423
+113
+9% +$2.06K ﹤0.01% 1954
2024
Q2
$23K Buy
1,310
+847
+183% +$17.5K ﹤0.01% 1758
2024
Q1
$11.9K Buy
463
+272
+142% +$6.82K ﹤0.01% 1965
2023
Q4
$4.7K Buy
+191
New +$4.36K ﹤0.01% 2264

Other funds holding XP

GAMMA Investing's XP Position: Q3 2026 in Review

GAMMA Investing increased its XP (XP) stake by 18% in Q3 2026, buying an estimated $35.2K and bringing the position to 13,081 shares worth $275K. The position accounts for 0.01% of the portfolio, ranked #1095.

GAMMA Investing first reported a position in XP in Q4 2023 and has held it in 12 quarters since. 7 funds tracked by Wall St. Rank hold XP as of Q3 2026.

  • GAMMA Investing held 13,081 shares of XP worth $275K as of Q3 2026.
  • GAMMA Investing bought 1,983 XP shares in Q3 2026, an estimated $35.2K.
  • XP made up 0.01% of GAMMA Investing's portfolio in Q3 2026, its #1095 holding.
  • GAMMA Investing first reported a position in XP in Q4 2023 and has held it in 12 quarters since.
  • 7 funds tracked by Wall St. Rank held XP as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.